|
MX2016011401A
|
|
Pharmaceutical compositions comprising levocetirizine.
|
|
EP1858866A1
|
|
Pyroglutamate salts and their use in the optical resolution of intermediates for the synthesis of dextrocetirizine and levocetirizine
|
|
WO2006050909A1
|
|
Novel forms of efletirizine dihydrochloride, processes for making them and pharmaceutical compositions including them
|
|
TW200605892A
|
|
Pharmaceutical composition of piperazine derivatives
|
|
WO2005077371A1
|
|
Use of levocetirizine for the preparation of a drug
|
|
EP1633359A1
|
|
Use of efletirizine for treating persistent allergic rhinitis
|
|
CA2514145A1
|
|
Piperazine derivatives and their use as synthesis intermediates
|
|
BR0316823A
|
|
Use of levocetirizine or a pharmaceutically acceptable salt thereof
|
|
AU2003201161A1
|
|
Formulations
|
|
TWI243061B
|
|
Tablet comprising cetirizine and pseudoephedrine
|
|
IL159287D0
|
|
Tablet comprising cetirizine and pseudoephedrine
|
|
TW200536828A
|
|
2-oxo-1-pyrrolidine derivatives, process for preparing them and their uses
|
|
TWI308912B
|
|
Process for preparing 2-oxo-1-pyrrolidine derivatives
|
|
EP1254104A1
|
|
Quaternary ammonium compounds and their use as anti-tussive agent
|
|
CA2393711A1
|
|
Quaternary salts of n-substituted cyclic or acyclic amines as pharmaceuticals
|
|
CA2393699A1
|
|
Quaternary ammonium compounds and their use as anti-tussive agents
|
|
CA2393706A1
|
|
Cyclic quaternary ammonium compounds
|
